BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, Ding D, Fang F, Shan G, Guan T, Zhang Y, Dai Y, Yao M, Peng B, Zhu Y, Cui L. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord 2018;20:144-52. [PMID: 29414288 DOI: 10.1016/j.msard.2018.01.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 2023:S1474-4422(22)00431-8. [PMID: 36706773 DOI: 10.1016/S1474-4422(22)00431-8] [Reference Citation Analysis]
2 Sun X, Liu M, Luo X, Yuan F, Wang C, Wang S, Xu Q, Zhang Y, Chen Y. Clinical characteristics and prognosis of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseases in China. BMC Pediatr 2022;22:666. [DOI: 10.1186/s12887-022-03679-3] [Reference Citation Analysis]
3 Berek K, Grams A, Uprimny C, Prieschl M, Ramberger M, Unterberger I, Deisenhammer F, Reindl M, Hegen H. Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review. BMC Neurol 2022;22:434. [DOI: 10.1186/s12883-022-02974-x] [Reference Citation Analysis]
4 Spagni G, Sun B, Monte G, Sechi E, Iorio R, Evoli A, Damato V. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2022. [DOI: 10.1136/jnnp-2022-330086] [Reference Citation Analysis]
5 Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Mult Scler J Exp Transl Clin 2022;8:20552173221128170. [PMID: 36311694 DOI: 10.1177/20552173221128170] [Reference Citation Analysis]
6 Qiao S, Zhang S, Wang Z, Wang L, Zhang R, Li H, Jin Y, Liu L, Wang M, Wang A, Liu X. Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China: A multi-center study. Front Immunol 2022;13:858766. [DOI: 10.3389/fimmu.2022.858766] [Reference Citation Analysis]
7 Bonner K, Aboul Nour H, Memon AB. Overlapping Autoimmune Neurological Syndrome: A Case Report of Triple-Positive Antibody. Cureus 2022. [DOI: 10.7759/cureus.29379] [Reference Citation Analysis]
8 Zhao C, Liu P, Zhao D, Ding J, Zhang G, Li H, Guo J. Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review. Brain Sciences 2022;12:995. [DOI: 10.3390/brainsci12080995] [Reference Citation Analysis]
9 Zhang S, Yang Y, Liu W, Li Z, Li J, Zhou D. Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review. Front Immunol 2022;13:857443. [DOI: 10.3389/fimmu.2022.857443] [Reference Citation Analysis]
10 Yin XJ, Zhang LF, Bao LH, Feng ZC, Chen JH, Li BX, Zhang J. Overlapping syndrome of recurrent anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein demyelinating diseases: A case report. World J Clin Cases 2022; 10(18): 6148-6155 [DOI: 10.12998/wjcc.v10.i18.6148] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pan J, Ovlyakulov B, Zhou L. Overlapping anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00697-w] [Reference Citation Analysis]
12 Jiang W, Sun X, Huang H, Sun H, Zhang S, He M, Yu X, Huang D, Wu L. Bilateral parafalcine cortical and leptomeningeal impairment: A characteristic pattern of MOG antibody disease and AQP4 neuromyelitis optica spectrum disorders? Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Li S, Wang M, Li H, Wang J, Zhang Q, Zhou D, Li J. Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection. Front Immunol 2022;13:799454. [DOI: 10.3389/fimmu.2022.799454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lei X, Guo S, Cui S, Pu Y, Zhang A, He D. Clinical Profile and Treatment Outcome in MOGAD: A Single-Center Case-Series Study in Guiyang, China. Front Neurol 2022;13:830488. [DOI: 10.3389/fneur.2022.830488] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chan JS, Nurul-Ain M, Mohamad NF, Wan Hitam WH, Thavaratnam LK. Recurrent Optic Neuritis in Paediatric Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis: Case Report and Literature Review. Neuroophthalmology 2022;46:258-63. [PMID: 35859635 DOI: 10.1080/01658107.2021.2014892] [Reference Citation Analysis]
16 周 雪. Demyelinating Diseases of the Central Nervous System and Seizures. ACM 2022;12:2329-2333. [DOI: 10.12677/acm.2022.123335] [Reference Citation Analysis]
17 Li Y, Xie H, Zhang J, Zhou Y, Jing L, Yao Y, Duan R, Jia Y. Clinical and Radiological Characteristics of Children and Adults With First-Attack Myelin Oligodendrocyte Glycoprotein Antibody Disease and Analysis of Risk Factors for Predicting the Severity at Disease Onset in Central China. Front Immunol 2021;12. [DOI: 10.3389/fimmu.2021.752557] [Reference Citation Analysis]
18 Chen X, Ren Y, Zhang Y, Lu W. Comparative study of AQP4 antibody-related diseases and MOG antibody-related diseases among the population in Hunan, China. Acta Neurol Belg 2021;121:1649-59. [PMID: 32737792 DOI: 10.1007/s13760-020-01455-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Caparó-Zamalloa C, Castro-Suarez S, Cortez-Escalante J, Aguirre-Quispe W, Guevara-Silva E, Osorio-Marcatinco V, Meza-Vega M. Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort. Heliyon 2021;7:e08069. [PMID: 34765756 DOI: 10.1016/j.heliyon.2021.e08069] [Reference Citation Analysis]
20 Wang J, Qiu Z, Li D, Yang X, Ding Y, Gao L, Liu A, Song Y, Li C, Gao R, Wang L, Wu L, Jia L, Guo D, Zhou A, Jia J, Huang L, Qu M, Gao L, Dong H, Hao J, Liu Z. Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies. Front Immunol 2021;12:722404. [PMID: 34691028 DOI: 10.3389/fimmu.2021.722404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tang H, Wang L, Zhou H, Hao X. Psychiatric symptoms as initial manifestation in neuromyelitis optica spectrum disorder without cortical lesions: A report of two cases. J Neuroimmunol 2021;359:577693. [PMID: 34403863 DOI: 10.1016/j.jneuroim.2021.577693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ding J, Li X, Tian Z. Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:711376. [PMID: 34512521 DOI: 10.3389/fneur.2021.711376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Guang S, Ma J, Ren X, Zhou S, Yang J, Zhang J, Cao X, Zhong L, Ding X, Wang X, Ren C, Zhang W, Zhang L, Zhang M, Sun J, Kessi M, Yin F, Peng J, Jiang Y. Immunotherapies for Anti-N-M-methyl-D-aspartate Receptor Encephalitis: Multicenter Retrospective Pediatric Cohort Study in China. Front Pediatr 2021;9:691599. [PMID: 34268281 DOI: 10.3389/fped.2021.691599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Li X, Zhang C, Jia D, Fan M, Li T, Tian DC, Liu Y, Shi FD. The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis. Mult Scler Relat Disord 2021;53:103030. [PMID: 34118585 DOI: 10.1016/j.msard.2021.103030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Chen W, Li Q, Wang T, Fan L, Gao L, Huang Z, Lin Y, Xue Q, Liu G, Su Y, Zhang Y. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity? Mult Scler Relat Disord 2021;52:103020. [PMID: 34034214 DOI: 10.1016/j.msard.2021.103020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Chen T, Bosco DB, Ying Y, Tian DS, Wu LJ. The Emerging Role of Microglia in Neuromyelitis Optica. Front Immunol 2021;12:616301. [PMID: 33679755 DOI: 10.3389/fimmu.2021.616301] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
27 Gong X, Chen C, Liu X, Lin J, Li A, Guo K, Zhou D, Hong Z. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China. Neurol Neuroimmunol Neuroinflamm 2021;8:e958. [PMID: 33589542 DOI: 10.1212/NXI.0000000000000958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
28 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. Anti-NMDAR Encephalitis with Relapsing Optic Neuritis. Neurosci Behav Physi 2021;51:163-170. [DOI: 10.1007/s11055-021-01053-x] [Reference Citation Analysis]
29 Mader S, Kümpfel T, Meinl E. Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases. Curr Opin Neurol 2020;33:362-71. [PMID: 32304439 DOI: 10.1097/WCO.0000000000000813] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
30 Cross H, Sabiq F, Ackermans N, Mattar A, Au S, Woodhall M, Sun B, Devonshire V, Carruthers R, Sayao AL, Bhan V, Schabas A, Chan J, Fritzler M, Waters P, Traboulsee A. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort. Front Neurol 2020;11:525933. [PMID: 33510701 DOI: 10.3389/fneur.2020.525933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Cao L, Ren L, Huang X. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report. Medicine (Baltimore) 2021;100:e24234. [PMID: 33429822 DOI: 10.1097/MD.0000000000024234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Nan D, Zhang Y, Han J, Jin T. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature. Neurol Sci 2021;42:847-55. [PMID: 33409829 DOI: 10.1007/s10072-020-04942-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 彭 梦. Analysis of 9 Clinical Cases of Children with MOG Antibody-Associated Diseases. ACM 2021;11:2449-2455. [DOI: 10.12677/acm.2021.115353] [Reference Citation Analysis]
34 Lovera J, Feria OV, Losada Leon V. Inflammatory Conditions of the Hypothalamus. The Human Hypothalamus 2021. [DOI: 10.1007/978-3-030-62187-2_20] [Reference Citation Analysis]
35 Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C, Wassmer E, Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K; E.U. paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 2020;29:2-13. [PMID: 33162302 DOI: 10.1016/j.ejpn.2020.10.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
36 Du L, Wang H, Zhou H, Chang H, Wei Y, Cong H, Xu W, Ma Y, Song T, Zhang X, Yin L. Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational study. Medicine (Baltimore) 2020;99:e21238. [PMID: 32756102 DOI: 10.1097/MD.0000000000021238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
37 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. [Anti-NMDAR encephalitis associated with relapsing optic neuritis]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:105-13. [PMID: 32678556 DOI: 10.17116/jnevro2020120061105] [Reference Citation Analysis]
38 Antel JP, Becher B, Ludwin SK, Prat A, Quintana FJ. Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System. J Immunol 2020;204:251-5. [PMID: 31907266 DOI: 10.4049/jimmunol.1900908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
39 Foiadelli T, Gastaldi M, Scaranzin S, Franciotta D, Savasta S. Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: Two paradigmatic cases and a review of the literature. Multiple Sclerosis and Related Disorders 2020;41:102011. [DOI: 10.1016/j.msard.2020.102011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
40 Rocca MA, Cacciaguerra L, Filippi M. Moving beyond anti-aquaporin-4 antibodies: emerging biomarkers in the spectrum of neuromyelitis optica. Expert Review of Neurotherapeutics 2020;20:601-18. [DOI: 10.1080/14737175.2020.1764352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Li S, Ren H, Xu Y, Xu T, Zhang Y, Yin H, Zhang W, Li J, Ren X, Fang F, Li W, Zhu Y, Peng B, Wang J, Zhong Y, Cui L. Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: A prospective study. Neurol Neuroimmunol Neuroinflamm 2020;7:e705. [PMID: 32170045 DOI: 10.1212/NXI.0000000000000705] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
42 Yoshimura M, Uehara T, Tanaka E, Okadome T, Yamaguchi T, Maeda Y, Isobe N, Matsushita T, Yamasaki R, Kira J. Double positivity for anti‐ N ‐methyl‐ d ‐aspartate receptor and anti‐aquaporin‐4 antibodies in a patient presenting with hypersomnolence, personality change, and reduced spontaneity. Clin Exp Neuroimmunol 2020;11:53-56. [DOI: 10.1111/cen3.12571] [Reference Citation Analysis]
43 Hou C, Wu W, Tian Y, Zhang Y, Zhu H, Zeng Y, Peng B, Zheng K, Li X, Chen W. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children. Mult Scler Relat Disord 2020;42:102018. [PMID: 32234601 DOI: 10.1016/j.msard.2020.102018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
44 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. [Anti-NMDAR encephalitis associated with relapsing optic neuritis: a case report and differential diagnosis]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:137-46. [PMID: 31934999 DOI: 10.17116/jnevro201911910137] [Reference Citation Analysis]
45 Pérez CA, Agyei P, Gogia B, Harrison R, Samudralwar R. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease. Journal of Neuroimmunology 2020;339:577124. [DOI: 10.1016/j.jneuroim.2019.577124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
46 Yang L, Li H, Xia W, Quan C, Zhou L, Geng D, Li Y. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders. Eur Radiol 2020;30:1470-9. [PMID: 31748853 DOI: 10.1007/s00330-019-06506-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
47 Taraschenko O, Zabad R. Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures. Epilepsy Behav Rep 2019;12:100338. [PMID: 31737864 DOI: 10.1016/j.ebr.2019.100338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
48 Papathanasiou A, Tanasescu R, Davis J, Rocha MF, Singhal S, O’donoghue MF, Constantinescu CS. MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity. J Neurol 2020;267:359-68. [DOI: 10.1007/s00415-019-09586-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
49 Xu X, Lu Q, Huang Y, Fan S, Zhou L, Yuan J, Yang X, Ren H, Sun D, Dai Y, Zhu H, Jiang Y, Zhu Y, Peng B, Cui L, Guan H. Anti-NMDAR encephalitis: A single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm. 2020;7. [PMID: 31619447 DOI: 10.1212/nxi.0000000000000633] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 14.5] [Reference Citation Analysis]
50 Kammeyer R, Piquet AL. Multiple co-existing antibodies in autoimmune encephalitis: A case and review of the literature. J Neuroimmunol 2019;337:577084. [PMID: 31655424 DOI: 10.1016/j.jneuroim.2019.577084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
51 Aoe S, Kokudo Y, Takata T, Kobara H, Yamamoto M, Touge T, Deguchi K, Masaki T. Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report. Multiple Sclerosis and Related Disorders 2019;35:182-4. [DOI: 10.1016/j.msard.2019.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
52 Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B. [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]. Nervenarzt 2018;89:1388-99. [PMID: 30264269 DOI: 10.1007/s00115-018-0607-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
53 Mao L, Yang L, Kessi M, He F, Zhang C, Wu L, Yin F, Peng J. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes. Front Neurol 2019;10:868. [PMID: 31440204 DOI: 10.3389/fneur.2019.00868] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
54 Tao S, Zhang Y, Ye H, Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Mult Scler Relat Disord 2019;35:185-92. [PMID: 31398657 DOI: 10.1016/j.msard.2019.07.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Deng S, Qiu K, Liu H, Wu X, Lei Q, Lu W. Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China. Front Neurol 2019;10:539. [PMID: 31178819 DOI: 10.3389/fneur.2019.00539] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
56 Rojc B, Podnar B, Graus F. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies. Journal of Neuroimmunology 2019;328:86-8. [DOI: 10.1016/j.jneuroim.2018.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
57 Sarigecili E, Cobanogullari MD, Komur M, Okuyaz C. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child. Multiple Sclerosis and Related Disorders 2019;28:101-3. [DOI: 10.1016/j.msard.2018.12.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
58 Zhou J, Lu X, Zhang Y, Ji T, Jin Y, Xu M, Bao X, Zhang Y, Xiong H, Chang X, Jiang Y, Wu Y. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination. Multiple Sclerosis and Related Disorders 2019;28:4-10. [DOI: 10.1016/j.msard.2018.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
59 Nosadini M, Mohammad SS, Toldo I, Sartori S, Dale RC. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review. European Journal of Paediatric Neurology 2019;23:7-18. [DOI: 10.1016/j.ejpn.2018.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
60 Mcclelland CM, Lee MS, Gans MS. Optic Neuritis as the Presenting Feature of Neuromyelitis Optica (NMO): Diagnosis and Management. Neuro-Ophthalmology 2019. [DOI: 10.1007/978-3-319-98455-1_2] [Reference Citation Analysis]
61 Ni J, Han F, Yuan J, Wang H, Shen DC, Xu Y, Cui LY. The Discrepancy of Neurological Diseases between China and Western Countries in Recent Two Decades. Chin Med J (Engl) 2018;131:886-91. [PMID: 29664046 DOI: 10.4103/0366-6999.229905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
62 Yao Y, Xu Y, Ren H, Zhou X, Jin L, Huang Y, Lu Q, Yang X, Zhang Y, Zhu Y, Peng B, Cui L. Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study. Mult Scler Relat Disord 2019;27:281-8. [PMID: 30448468 DOI: 10.1016/j.msard.2018.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
63 Wang L, Zhangbao J, Zhou L, Zhang Y, Li H, Li Y, Huang Y, Wang M, Lu C, Lu J, Zhao C, Quan C. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single‐center cohort study in Shanghai, China. Eur J Neurol 2018;26:168-74. [DOI: 10.1111/ene.13790] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
64 Zhou J, Tan W, Tan SE, Hu J, Chen Z, Wang K. An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis. Journal of Neuroimmunology 2018;320:107-10. [DOI: 10.1016/j.jneuroim.2018.03.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
65 Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018;15:134. [PMID: 29724224 DOI: 10.1186/s12974-018-1144-2] [Cited by in Crossref: 388] [Cited by in F6Publishing: 403] [Article Influence: 77.6] [Reference Citation Analysis]